- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00661908
Diabetes-Related Discrimination at Workplace and by Insurances
Discrimination of Insulin-Treated Diabetic Subjects at the Workplace and by Insurances
Diabetic subjects often report of problems at the workplace or when contracting insurances because of their diabetes.
By distributing a self-report questionnaire to insulin-treated Type 1 and Type 2 diabetic subjects we wanted to analyse the frequency of work- and insurance-related discrimination. Furthermore we wanted to detect socio-demographic and diabetes-related factors which are associated with increased discrimination at workplace and by insurances. We hypothesized that diabetes-related discrimination at workplace and by insurances exists and that certain factors like having severe hypoglycaemic events, being type 1 diabetic or being overweight would be associated with more problems at work or with insurances.
Study Overview
Status
Conditions
Detailed Description
Our self report questionnaire included 83 items to assess treatment goals, quality of life and discrimination at workplace or by insurances. 636 questionnaires were distributed and were answered and returned. Anonymity was ensured. Patients were recruited from the diabetes outpatient clinic of the University of Basel Hospital, 5 regional hospitals, specialist practices and general practitioner practices.
The aims of this study are to investigate the prevalence of discrimination at workplace and by insurances due to diabetes mellitus. Furthermore we want analyse if socio-demographic factors (age,gender,origin) show an impact on diabetes-related discrimination at workplace and by insurances. We hypothesize furthermore that certain diabetes-related factors like having severe hypoglycemias, being type 1 diabetic, having diabetic complications or being overweight/obese is associated with more problems at work and with insurances.
Data will be analysed by a multiple ordinal regression analysis. We will correct data for age, gender, employment status and diabetes type.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- german-speaking insulin-treated diabetic patients
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
1
insulin-treated diabetic subjects of North-western part of Switzerland
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Piera M Nebiker, MD, University of Basel
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 274/03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin-Treated Diabetes Mellitus
-
Izmir Bakircay UniversityCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 2 Treated With InsulinTurkey (Türkiye)
-
Aalborg University HospitalNovo Nordisk A/S; DexCom, Inc.RecruitingType 2 Diabetes Treated With InsulinDenmark
-
DiabeloopUniversity Hospital, Grenoble; AGIR à Dom; Icadom; Centre Hospitalier Annecy Genevois and other collaboratorsCompletedDiabetes Mellitus Type 2 - Insulin-TreatedFrance
-
Shanghai Zhongshan HospitalCompleted
-
Diabetes Free, Inc.Not yet recruitingDiabetes Mellitus Type 2 - Insulin-Treated
-
Linda SiminerioSanofiTerminatedDiabetes Mellitus Type 2 - Insulin-TreatedUnited States
-
Deka Research and DevelopmentSequel Med TechCompletedType 2 Diabetes | Insulin Treated Type 2 Diabetes MellitusUnited States
-
Universiti Sains MalaysiaClinical Research Centre, Malaysia; Malaysia Palm Oil BoardTerminatedUncontrolled Insulin-treated Type 2 Diabetes MellitusMalaysia
-
Hospital Universitario San IgnacioRecruitingDiabetes Mellitus, Type 2 Treated With InsulinColombia
-
Pacific Diabetes TechnologiesOregon Health and Science UniversityNot yet recruitingAssessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 DiabetesType 2 Diabetes Treated With Insulin